The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Baseline subclinical sensory deficits and the development of pain and numbness in patients with multiple myeloma (MM) being treated with chemotherapy.
Elisabeth G. Vichaya
No relevant relationships to disclose
Xin Shelley Wang
No relevant relationships to disclose
Jessica A. Boyette-Davis
No relevant relationships to disclose
Zijing He
No relevant relationships to disclose
Sheeba K. Thomas
No relevant relationships to disclose
Nina Shah
No relevant relationships to disclose
Tito R. Mendoza
No relevant relationships to disclose
Loretta A. Williams
No relevant relationships to disclose
Charles S. Cleeland
No relevant relationships to disclose
Patrick M. Dougherty
Research Funding - AstraZeneca